DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
New Delhi | The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of...
Bharat Biotech
Bharat Biotech refuse more Covaxin to Delhi, Covishield stock to reach today
New Delhi | There is no stock of -- Covaxin for those between 18-45 of age and around 100 newly setup...
Bharat Biotech begins Covaxin supplies to 14 states
Hyderabad | Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states. The states are Andhra Pradesh,...
Bharat Biotech cuts price of Covaxin for states
Hyderabad | Bharat Biotech on Thursday announced that it is slashing the price of its Covid-19 vaccine Covaxin to Rs 400,...
Bharat Biotech scales up manufacturing of Covaxin
Hyderabad | Leading vaccine maker Bharat Biotech on Tuesday announced scaling up of manufacturing capacity to produce about 700 million doses...
To boost vaccine production Centre gives nod for credit support to Serum Institute, Bharat Biotech
New Delhi | In a bid to boost vaccine production amid rising Covid cases, the Centre has given in-principle approval for...
Covaxin has no serious side effects, says Lancet
Hyderabad: Covaxin, India's first indigenous vaccine for Covid-19, is "safe, immunogenic with no serious side effects", says leading medical journal The...
Chinese hackers target SII, Bharat Biotech: Report
New Delhi: Chinese and Russian-linked hacking campaigns in recent weeks targeted Indian vaccine makers Serum Institute of India (SII) and Bharat...
13,000 volunteers given 2nd dose of Covaxin: Bharat Biotech
Hyderabad (3 Min Read): Bharat Biotech on Friday announced that 13,000 volunteers have been successfully administered the second dose of its...
Avoid Covaxin in case of allergies, fever: Bharat Biotech
Hyderabad (2 Min Read): Bharat Biotech, makers of India's first indigenous vaccine for Covid-19, has advised people not to take 'Covaxin'...
